Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

EBRD to provide €30 million of long-term financing to Rönesans Gayrimenkul Yatırım to support regions affected by 2023 earthquakes




Loan to finance support capex of the shopping centres in the region and projects to help preserve livelihoods in the affected cities

ISTANBUL, March 28, 2024 /PRNewswire/ — The European Bank for Reconstruction and Development (EBRD) is providing a senior loan of € 30 million to Rönesans Gayrimenkul Yatırım A.Ş (Rönesans Real Estate Investment) subsidiary of Rönesans Holding, one of Europe’s leading contracting and investment companies.

Rönesans Gayrimenkul Yatırım (RGY) is the commercial real estate development and investment company of Rönesans Holding. Combining Rönesans Holding’s over 30 years of construction experience with 22 years of real estate experience, RGY has an asset portfolio of 16 real estate properties with a gross asset value of € 2,6 billion as of 2023YE. Rönesans Gayrimenkul Yatırım stands as Türkiye’s largest commercial real estate investment group with its own managed projects, totaling c.1,500,000 square meters of gross building area and c. 740,000 square meters of gross leasable area.

The loan will finance the support capex of Kahramanmaraş and Şanlıurfa Piazza Shopping Centres and will be backed by a guarantee from the European Union.

The project will support the preservation of human capital and the livelihoods in the region. Rönesans Gayrimenkul Yatırım will provide a skills development programme and crafts production trainings dedicated to women. The sales training will prove beneficial to Kahramanmaraş Piazza Shopping Centre’s tenants who are facing labour shortages following significant migration from the city after the earthquake.

Jürgen Rigterink, First Vice President and Head of Client Services Group of the EBRD, said: “I was shocked and saddened to see during my visit the devastating impact the earthquakes have had on the affected region, and I continue to be inspired by the resilience and determination of the local population here.”

“Reconstruction is a long process and can take many years, but it begins by allowing the private sector to regain its vibrant potential. I am proud to say that we have already made available more than half of our initial €1.5 billion investment response, and we will continue to stand with Türkiye on its path to recovery by supporting projects that preserve the livelihoods of the region.”

İpek Ilıcak Kayaalp, Chair of the Board of Directors of Rönesans Holding, said: “We have a strong and longstanding partnership with EBRD for 15 years, and we are happy to collaborate with them on our social infrastructure investment projects in Türkiye and potential projects in Central Asia. We have secured over €500 million in financing from EBRD for our healthcare investment projects in the past, and we are now extending our collaboration to the real estate sector in Türkiye. I believe that our partnership will contribute to the ongoing recovery efforts in the earthquake-affected region, as part of our efforts to implement impactful projects to mitigate the effects of earthquakes.”

Kahramanmaraş Piazza is the only shopping centre in the city of Kahramanmaraş. Despite its location directly above the fault line, it remained intact and became a crucial focal point for the entire city following the February 6 earthquakes. It served as a help centre for urgent needs such as food and shelter for 1,000 people as a part of Rönesans Holding’s earthquake relief efforts, under the leadership of Erman Ilıcak, the President of Rönesans Holding.

Immediately following the 2023 earthquakes, Rönesans Holding and its 2,000 volunteers moved quickly to provide urgent needs for earthquake victims. Within two months of the devastating earthquakes, Rönesans Holding had created temporary living spaces designed for more than 10,000 people, prioritising the wellbeing of the most vulnerable members of society, especially women, children, and young people. The business has continued to support the relief and recovery efforts, launching additional programs to support the education and mental health of those affected by the earthquakes in recent months.

Rönesans Gayrimenkul Yatırım has also been an early leader in green building and implementing energy-saving initiatives since 2017, aiming to cover 40% of its energy consumption with renewable sources by 2025 and achieve 100% renewable energy usage in all projects by 2028. Rönesans Gayrimenkul Yatırım is intensively pursuing solar energy utilization in projects where climate conditions permit, to this end. With a particular focus on solar energy usage, it has achieved a pioneering milestone by obtaining the highest level of BREEAM In-Use certification for its portfolio of 10 properties, marking a groundbreaking achievement as the first in Türkiye and globally.

As of the end of 2023, Rönesans Gayrimenkul Yatırım , which has achieved an occupancy rate of over 97% in its shopping malls and welcomes close to 100 million visitors annually, continues its review process for its public offering, having submitted its applications to the Capital Markets Board (SPK) and Borsa Istanbul.

About Rönesans Group

Rönesans Holding, the conglomerate’s top investment entity headquartered in Ankara, is the 38th largest international contracting company globally and the 9th largest in Europe. With operations spanning 30 countries across Europe, Central Asia, and Africa, including subsidiaries such as Ballast
Nedam in the Netherlands and Heitkamp Industrial Solutions GmbH in Germany, Rönesans has been operating as the main contractor and investor successfully for 30 years in construction, real estate development, healthcare and energy. Putting resilience and growth through innovation at the core of the company, with a priority on sustainability and social development, Rönesans has developed projects supporting students with scholarships, academic platforms and initiatives; been a signatory of the UN Global Compact since 2015; and a signatory of the UN Women’s Empowerment Principles since 2016.

Rönesans Holding, under the leadership of its president, Erman Ilıcak, along with its partners GIC, Meridiam Infrastructure, Sojitz, Samsung C&T, TotalEnergies, and IFC of the World Bank Group (a minority shareholder in the group), has invested more than EUR8 billion into pioneering projects globally.

Photo –
Logo –


Rönesans Holding


Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading